ANCA-associated vasculitis: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• CD19 30
• BCMA 14
• CD20 2
• AKT 0
• CTLA-4 0
• CD38 1
• IL-15 1
• IL-4 0
• mTOR 0
• PI3K 0
• SGLT2 1
• STAT3 0
• VEGF 0

6 of 6+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAID · F30

  Regulation of type I interferon signaling by A20 (TNFAIP3) in autoimmune and autoinflammatory disease

  University of Pittsburgh at Pittsburgh· Pittsburgh, United States· US$55,114 awarded in fiscal year 2026· until Oct 2029

• NIH NCCIH · R34

  Virtual Rheum: The Development of a Virtual Mind-Body Resiliency Intervention for Patients with ANCA-Associated Vasculitis and Systemic Lupus Erythematosus

  Massachusetts General Hospital· Boston, United States· US$770,399 awarded in fiscal year 2026· until Aug 2029

• NIH NHLBI · R01

  Cell-free RNA signature for Diagnosis and Personalized Therapeutics in Children with Kawasaki Disease

  University of California, San Diego· La Jolla, United States· US$1,639,166 awarded in fiscal year 2026· until Jun 2028

• NIH NIAID · R01

  Gastrointestinal tissue-adapted eosinophils in health and disease

  University of Colorado Denver· Aurora, United States· US$771,983 awarded in fiscal year 2026· until Aug 2031

• NIH NIAID · R56

  Investigation of human immune responses in acute rickettsioses: towards development of host response-based diagnostics

  Duke University· Durham, United States· US$807,481 awarded in fiscal year 2026· until Aug 2027

• European Commission (Horizon Europe) · HORIZON-CSA

  TwinDEEPS – Twinning deep-ocean exploration and observation capacity for sustainable development

  Centro Interdisciplinar de Investigacao Marinha e Ambiental· Matosinhos, Portugal· EU contribution €1,498,973· until Jun 2027· 4 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Mucosal Breaks of Bacteria Trigger Pathogenic B-cell Responses in ANCA-associated Vasculitis (Breaking ANCA)

  Academisch Ziekenhuis Leiden· Leiden, Netherlands· EU contribution €296,296· until Apr 2028· 2 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  EXPanding AAV gene therapy by EDITing (EXPEDITE)

  Fondazione Telethon Ets· Roma, Italy· EU contribution €2,492,303· until Oct 2028

• European Commission (Horizon Europe) · HORIZON-RIA

  Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites (TiilT)

  Sorbonne Universite· Paris, France· EU contribution €5,605,576· until May 2028· 6 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-EIC

  Next-generation AAV vectors for liver-directed gene therapy (AAVolution)

  Fondazione Telethon Ets· Roma, Italy· EU contribution €4,500,000· until Sept 2027· 5 countries

10 of 72 running projects, newest first. Listed amounts together: US$35.5m + €14.4m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 2
• Mendelian Randomization Analysis 1
• Gene Expression Profiling 8
• Proteomics 2
• Metabolomics 1
• Mass Spectrometry 1
• Flow Cytometry 1
• Magnetic Resonance Imaging 14
• Machine Learning 3
• Cohort Studies 16
• Genome-Wide Association Study 3

• Exploration of the genetic architecture of ANCA-associated vasculitis.

  EBioMedicine, Oct 2026

• Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations.

  RMD Open, Jul 2026

• Impact of Infection-Related Immune Responses on ANCA-Associated Vasculitis in Finns: A Mendelian Randomization Study.

  Genet Res (Camb), Jan 2026

See which targets of this disease your abstract mentions, and go to the people working on them.